Guillermo J Ruiz-Delgado (G J Ruiz-Delgado)

Publication Activity (10 Years)

Years Active: 2019-2022
Publications (10 Years): 4

Top Topics

Allogeneic Hematopoietic Stem Cell Transplantation

Multiple Myeloma

Acute Lymphoblastic Leukemia

Top Venues

Hematology (Amsterdam, Netherlands)

Leukemia & lymphoma

Clinical and experimental immunology

This page only lists publications with an associated author ORCID identifier.

Publications

José Antonio Fernández-Gutiérrez, Oscar A Reyes-Cisneros, Mark R Litzow, Lorena Bojalil-Alvarez, Elizabeth Garcia-Villaseñor, Eliezer Tomas Gómez-Gomez, Ivan Murrieta, Guillermo José Ruiz Argüelles, Cesar Homero Gutiérrez-Aguirre, Amado J Karduss-Urueta, Guillermo J Ruiz-Delgado, Guillermo José Ruiz-Arguelles
High dose melphalan is an adequate preparative regimen for autologous hematopoietic stem cell transplantation in relapsed/refractory lymphoma. Hematology (Amsterdam, Netherlands) 27 (1) (2022)
Perla Rocio Colunga-Pedraza, Julia Esther Colunga-Pedraza, Samantha P Peña-Lozano, Andrés Gómez-De León, Guillermo J Ruiz-Delgado, Raul C Ribeiro
Diagnosis and treatment of acute lymphoblastic leukemia in Latin America. Hematology (Amsterdam, Netherlands) 27 (1) (2022)
Lorena Bojalil-Alvarez, Morie A Gertz, Elizabeth Garcia-Villaseñor, José Antonio Fernández-Gutiérrez, Oscar Alfonso Reyes-Cisneros, Ivan Murrieta, Yahveth Cantero-Fortiz, Guillermo J Ruiz-Delgado, Guillermo José Ruiz-Arguelles
Long term survival in multiple myeloma: a single institution experience in underprivileged circumstances. Leukemia & lymphoma 63 (5) (2021)
Guillermo José Ruiz-Arguelles, J C Olivares-Gazca, M Olivares-Gazca, A A Leon-Peña, I Murrieta-Alvarez, Y Cantero-Fortiz, G B Gomez-Cruz, Alejandro Ruiz-Argüelles, M Priesca-Marin, Guillermo J Ruiz-Delgado
Self-reported changes in the expanded disability status scale score in patients with multiple sclerosis after autologous stem cell transplants: real-world data from a single center. Clinical and experimental immunology 198 (3) (2019)